Key Takeaways
- Corteva Agriscience and Swedish crop nutrition company Arevo have announced a partnership to integrate Arginex Soy — an arginine-based seed treatment — into Corteva's soybean seed treatment portfolio across EMEA markets.
- Arginex Soy works by stimulating root hair growth to increase nodulation and improve nitrogen fixation by beneficial soil bacteria, supporting healthier early-stage crop development and more efficient nutrient use.
- The agreement follows a multi-stage technical evaluation assessing agronomic performance, formulation stability, and operational compatibility with Corteva's existing seed treatment systems, all of which the product passed.
- Arginex Soy is already commercially available to farmers in Europe; the Corteva partnership is designed to scale access through established commercial distribution channels, reducing adoption barriers for growers.
- The deal represents a significant commercial milestone for Arevo, confirming that its Arginex platform can be integrated into major established seed treatment systems.
Corteva Adds Arevo Arginex Soy to Soybean Seed Treatment Portfolio
Corteva Agriscience and Arevo, a Swedish science-led crop nutrition company, have announced a commercial partnership centered on Arginex Soy, Arevo's arginine-based seed treatment system. Under the agreement, Corteva will integrate Arginex Soy into its soybean seed treatment portfolio, giving growers access to the technology through Corteva's existing commercial channels. The product is already sold to farmers in Europe and the partnership is designed to broaden its reach.
Arginex Soy works by applying arginine — an amino acid involved in plant signaling and metabolism — directly to soybean seed at planting. In soybeans, arginine helps stimulate the growth of root hairs, which are critical for the formation of nodules where nitrogen-fixing bacteria establish. By supporting this process from germination, the treatment aims to strengthen the plant's natural nitrogen fixation capacity, improve root development, and increase nutrient use efficiency during the earliest and most vulnerable stages of crop establishment.
Leonardo Costa, EMEA Seed Applied Technologies Leader at Corteva Agriscience, described what the evaluation process confirmed:
“Rigorous evaluation has confirmed that Arginex Soy delivers the consistency and formulation stability required for Corteva's seed applied technologies. This enables seamless integration into existing systems and provides farmers with a practical solution to support early crop establishment and improve nutrient use efficiency from the start,” said Leonardo Costa, EMEA Seed Applied Technologies Leader, Corteva Agriscience.
What the Technical Evaluation Covered
The partnership followed a multi-stage assessment examining Arginex Soy across three dimensions: agronomic performance in field conditions, formulation stability under commercial handling, and operational compatibility with Corteva's existing seed treatment processes. The evaluation confirmed the product met Corteva's standards on all counts, and that it can be applied without modifications to existing treatment equipment or workflows — a key factor in reducing friction for growers considering adoption.
For Arevo, securing a partnership with one of the world's largest agriculture companies following this level of scrutiny represents a meaningful step in the commercial validation of its Arginex platform. Niklas Åström, Chief Executive Officer of Arevo, noted the significance of the outcome:
“Being selected following this level of technical evaluation is an important milestone for Arevo. It confirms that Arginex can be integrated into established seed platforms,” said Niklas Åström, Chief Executive Officer, Arevo.
Sustainable Production and Corteva Grower Access
Beyond yield performance, Arginex Soy is positioned as a tool for more sustainable soybean production. By improving the crop's natural nitrogen fixation rather than supplementing with synthetic nitrogen inputs, the treatment targets reduced external input dependency while maintaining or improving output. Corteva's integration of the product into its portfolio means growers can access the technology through familiar distribution relationships rather than seeking out a new supplier — a deliberate design element of the commercial agreement.
